M.D., Ph.D., Tenaya’s Chief Medical Officer. “The robust transduction and improvements in cardiac function observed in a model of severe disease, provide reason to believe in TN-201’s ...

We’re delighted to welcome Leone as Chair of the Board’s Audit Committee,” said David Hallal, Chairman of the Kalaris Board of Directors. “Leone is joining us at the pinnacle of her career as a senior ...

Insiders have lately been showing their love for these three biotech stocks, two tech stocks, and a utility stock with huge ...

Ms. Patterson previously served as Chief Financial and Business Officer at Tenaya Therapeutics where she led corporate finance, investor relations, corporate communications, strategy and business ...

Her previous roles include Chief Financial and Business Officer at Tenaya Therapeutics and leadership positions at Adverum Biotechnologies, Diadexus, Transcept, Exelixis, Novartis, and Chiron.

Rocket Pharmaceuticals' gene therapies offer long-term effects for cardiovascular and hematology diseases. Read why I rate ...

Note that the buyer also picked up some shares of Tenaya Therapeutics Inc. (NASDAQ ... Note that the outgoing chief executive bucked the trend, also acquiring more than $18 million worth of ...

Her previous roles include Chief Financial and Business Officer at Tenaya Therapeutics and leadership positions at Adverum Biotechnologies, Diadexus, Transcept, Exelixis, Novartis, and Chiron.